Key result
Impaired macrophage cholesterol efflux and surfactant catabolism drive pulmonary alveolar proteinosis pathogenesis.
Why the study?
Pulmonary alveolar proteinosis is characterized by surfactant accumulation due to defective alveolar macrophage maturation and surfactant clearance linked to disrupted GM-CSF signaling, with emerging evidence reframing it as a macrophage lipid-handling disorder.
No takes yet. Share an insight, caveat, or question.
This review reframes pulmonary alveolar proteinosis as a disorder of macrophage lipid handling, suggesting that targeting macrophage lipid homeostasis may offer new disease-modifying strategies.
Lee et al. (2026) conducted a review in Pulmonary alveolar proteinosis. Pulmonary alveolar proteinosis is increasingly understood as a disorder of macrophage lipid handling, where impaired cholesterol efflux and surfactant catabolism drive disease initiation and progression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: